AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 105 filers reported holding AERIE PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $124,000 | -20.0% | 10,500 | 0.0% | 0.06% | -25.3% |
| Q2 2020 | $155,000 | +9.2% | 10,500 | 0.0% | 0.08% | -6.0% |
| Q1 2020 | $142,000 | -44.1% | 10,500 | 0.0% | 0.08% | -25.0% |
| Q4 2019 | $254,000 | +25.7% | 10,500 | 0.0% | 0.11% | +27.3% |
| Q3 2019 | $202,000 | -34.8% | 10,500 | 0.0% | 0.09% | -36.7% |
| Q2 2019 | $310,000 | -37.9% | 10,500 | 0.0% | 0.14% | -39.0% |
| Q1 2019 | $499,000 | +31.7% | 10,500 | 0.0% | 0.23% | +0.4% |
| Q4 2018 | $379,000 | -41.3% | 10,500 | 0.0% | 0.23% | -38.1% |
| Q3 2018 | $646,000 | -8.9% | 10,500 | 0.0% | 0.37% | +2.2% |
| Q2 2018 | $709,000 | +24.4% | 10,500 | 0.0% | 0.36% | +18.9% |
| Q1 2018 | $570,000 | -9.1% | 10,500 | 0.0% | 0.30% | -5.6% |
| Q4 2017 | $627,000 | -30.3% | 10,500 | -43.2% | 0.32% | -34.6% |
| Q3 2017 | $899,000 | -7.5% | 18,500 | 0.0% | 0.49% | -14.5% |
| Q2 2017 | $972,000 | +15.9% | 18,500 | 0.0% | 0.57% | +6.9% |
| Q1 2017 | $839,000 | +10.8% | 18,500 | -7.5% | 0.54% | -2.7% |
| Q4 2016 | $757,000 | +0.3% | 20,000 | 0.0% | 0.55% | -18.2% |
| Q3 2016 | $755,000 | +114.5% | 20,000 | 0.0% | 0.67% | +149.8% |
| Q2 2016 | $352,000 | +44.9% | 20,000 | 0.0% | 0.27% | +61.1% |
| Q1 2016 | $243,000 | -50.1% | 20,000 | 0.0% | 0.17% | -51.7% |
| Q4 2015 | $487,000 | – | 20,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |